Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Goff

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scientific Reports|July 23, 2025
Enhancing aptamer selection in alzheimer's disease: integrating structure prediction and molecular dynamics simulationsBenedikt Jakob Lohnes, Aaron John Goff, Udo Frank Hartwig, et al.
Familial Cancer|October 19, 2022
Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMOTrevor L Hoffman, Hilary Kershberg, John Goff, et al.
Prenatal Diagnosis|September 10, 2014
Women's views and the impact of noninvasive prenatal testing on procedures in a managed care settingGeorge E Tiller, Hilary B Kershberg, John Goff, et al.
Applied Optics|November 21, 2002
Fixed three-dimensional holographic imagesClint Wood, Gregory J Salamo, John Goff, et al.
Journal of Medical Economics|May 21, 2011
Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart reviewHeidi Waters, Julie Vanderpoel, Scott McKenzie, et al.
JCO Oncology Practice|February 28, 2025
Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery SystemTrevor L Hoffman, Farah M Brasfield, Devansu Tewari, et al.
Journal of Medical Economics|October 26, 2011
Resource utilization before and during infliximab therapy in patients with inflammatory bowel diseaseHeidi C Waters, Julie E Vanderpoel, Bijan Nejadnik, et al.
Gastrointestinal Endoscopy|July 28, 2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitisPatrick Mosler, Stuart Sherman, Jeffrey Marks, et al.
Journal of Clinical Gastroenterology|October 22, 2008
Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter studyViju P Deenadayalu, Urszula Blaut, James L Watkins, et al.
Gastrointestinal Endoscopy|July 3, 2003
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter studyStuart Sherman, Urszula Blaut, James L Watkins, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 23, 2025
Enhancing aptamer selection in alzheimer's disease: integrating structure prediction and molecular dynamics simulationsBenedikt Jakob Lohnes, Aaron John Goff, Udo Frank Hartwig, et al.
Familial Cancer|October 19, 2022
Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMOTrevor L Hoffman, Hilary Kershberg, John Goff, et al.
Prenatal Diagnosis|September 10, 2014
Women's views and the impact of noninvasive prenatal testing on procedures in a managed care settingGeorge E Tiller, Hilary B Kershberg, John Goff, et al.
Applied Optics|November 21, 2002
Fixed three-dimensional holographic imagesClint Wood, Gregory J Salamo, John Goff, et al.
Journal of Medical Economics|May 21, 2011
Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart reviewHeidi Waters, Julie Vanderpoel, Scott McKenzie, et al.
JCO Oncology Practice|February 28, 2025
Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery SystemTrevor L Hoffman, Farah M Brasfield, Devansu Tewari, et al.
Journal of Medical Economics|October 26, 2011
Resource utilization before and during infliximab therapy in patients with inflammatory bowel diseaseHeidi C Waters, Julie E Vanderpoel, Bijan Nejadnik, et al.
Gastrointestinal Endoscopy|July 28, 2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitisPatrick Mosler, Stuart Sherman, Jeffrey Marks, et al.
Journal of Clinical Gastroenterology|October 22, 2008
Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter studyViju P Deenadayalu, Urszula Blaut, James L Watkins, et al.
Gastrointestinal Endoscopy|July 3, 2003
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter studyStuart Sherman, Urszula Blaut, James L Watkins, et al.
Pageof 2